Eterna Therapeutics Common Stock

Eterna Therapeutics (ERNA) currently reports a common stock of $6K as of March 2026. That compares with $260K in the prior-year period — down 97.7% year over year. Use the charts on this page to explore Eterna Therapeutics's common stock history and peer comparisons.

Eterna Therapeutics's common stock decreased from $260K to $6K — a 97.7% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Eterna Therapeutics reported $6K in common stock as of March 2026. That compares with $260K in the prior-year period — down 97.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $6K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Eterna Therapeutics, and consider following ERNA for alerts when major investors trade the stock.

Eterna Therapeutics is classified in the Telecommunications sector. On common stock, it currently shows $6K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Telecommunications are usually more informative than comparing ERNA with unrelated industries.